Most Californians support a measure to obtain state discounts on drugs
(By Ed Silverman for STAT) The pharmaceutical industry may be losing a heated battle over drug prices in California. Continue
Read More
Gilead fires back at medical journal report critical of its pricing
(By Ed Silverman for STAT) After getting beaten up last week over the pricing of its hepatitis C treatments in
Read MoreMedicare’s Next 50 Years: Preserving the Program for Future Retirees
(By Robert E. Moffit, Ph.D., for The Heritage Foundation) For 50 years, Medicare has managed to provide seniors with continuous
Read MoreMedicare’s Next 50 Years: Fix the Problems and Improve the Program
(By Jean Morrow for The Daily Signal) Medicare, the giant health program covering senior and disabled citizens, turned 51 on
Read MoreObamacare Expansion A Bumpy Ride For Rural Health Clinics
(By Pauline Bartolone for California Healthline) A network of clinics that serves low-income patients in rural Northern California is finally
Read MoreThe Costs Of The Pulse Nightclub Shooting
(By Abe Aboraya for Kaiser Health News) Mario Perez lives in Miami, but he was in Orlando for a housewarming
Read MoreMedicare’s Readmission Penalties Hit New High
(By Jordan Rau for Kaiser Health News) The federal government’s penalties on hospitals will reach a new high as Medicare
Read MoreAnother Three Bites the Dust
In July, three more Obamacare Co-ops, HealthyCt, Community Care of Oregon and Land of Lincoln announced they are closing. Read
Read MorePharmacy benefit managers are restricting access to lots of drugs next year
(By Ed Silverman for STAT) In the latest bid to control prescription drug spending, the nation’s largest pharmacy benefits managers
Read MoreThe ‘gouge factor’: Big companies want transparency in drug price negotiations
(By Ed Silverman for STAT) The path that prescription drugs take from the lab to your medicine chest is a
Read More